Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2022-11-17 00:00:00 ET · period of report 2022-11-16 · accession 0001415889-22-011523 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-17 | 2022-11-16 | TBPH | GRAHAM RICHARD A | SVP, RESEARCH, DEVELOPMENT | F - Tax | $11.20 | -2,800 | 343.0K | -0.8% | -$31.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-11-16 | F | D | 2,800 | $11.20 | 342,954 | D | — | — |